Goldman Sachs Adds Amgen, UnitedHealth, Dentsply Sirona To Conviction List

After a year of sector underperformance, several factors are coalescing to make 2020 a better year for the health care sector, Goldman Sachs said Monday as it added three stocks to its conviction list.

The Analyst

Asad Haider added Amgen, Inc. AMGNUnitedHealth Group Inc UNH and Dentsply Sirona Inc. XRAY to the firm’s Americas Conviction List.

Goldman has Buy ratings on all three stocks and a $270 price target on Amgen, a $330 price target on UnitedHealth and $66 price target on Dentsply Sirona. 

Takeways On Amgen, UnitedHealth, Dentsply Sirona 

Overall, Haider is more bullish on health care stocks generally and said he expects a rebound from a down year. 

A strong biotech innovation cycle is starting,and there’s a sense that any near-term aggressive government action is unlikely, with policymakers focused on the upcoming election, the analyst said. 

The policymaking landscape also includes a lower likelihood of Medicare-for-All in the next president's first term, as most candidates are not pushing the policy, he said. 

“Investors are entering 2020 with a better understanding of the heavy lifting required to legislate aggressive health care policy proposals,” Haider said. 

The analyst has above-consensus estimates for Amgen's revenue and EPS, adding that stock performance is likely to follow earnings revisions in a setting with receding headwinds and new pipeline readouts.

UnitedHealth Group also is likely to follow positive EPS revisions higher, “even if the multiple holds its slight historical relative P/E discount,” Haider said. 

Dentsply Sirona is likely to see continued demand for its Primescan Intraoral scanner product, leading to market share gains along with savings from restructuring tracking ahead of plan, the analyst said. 

Price Action

UnitedHealth Group shares were up 2.5% at the time of publication, while Amgen shares were higher by more than 3% and Dentsply Sirona shares were up 1.99%. 

Related Links:

Health Care ETFs Are Breaking Out, But Political Risks Linger In 2020

What You Need To Know About Elizabeth Warren's Plan To Pay For 'Medicare For All'

Posted In: 2020 electionAsad HaiderGoldman SachsmedicareAnalyst ColorHealth CarePrice TargetReiterationAnalyst RatingsGeneral

Ad Disclosure: The rate information is obtained by Bankrate from the listed institutions. Bankrate cannot guaranty the accuracy or availability of any rates shown above. Institutions may have different rates on their own websites than those posted on The listings that appear on this page are from companies from which this website receives compensation, which may impact how, where, and in what order products appear. This table does not include all companies or all available products.

All rates are subject to change without notice and may vary depending on location. These quotes are from banks, thrifts, and credit unions, some of whom have paid for a link to their own Web site where you can find additional information. Those with a paid link are our Advertisers. Those without a paid link are listings we obtain to improve the consumer shopping experience and are not Advertisers. To receive the rate from an Advertiser, please identify yourself as a Bankrate customer. Bank and thrift deposits are insured by the Federal Deposit Insurance Corp. Credit union deposits are insured by the National Credit Union Administration.

Consumer Satisfaction: Bankrate attempts to verify the accuracy and availability of its Advertisers' terms through its quality assurance process and requires Advertisers to agree to our Terms and Conditions and to adhere to our Quality Control Program. If you believe that you have received an inaccurate quote or are otherwise not satisfied with the services provided to you by the institution you choose, please click here.

Rate collection and criteria: Click here for more information on rate collection and criteria.